Johnston to replace Stolze as Stereotaxis CFO
This article was originally published in Clinica
Stereotaxis, developer of computer-controlled catheters and guidewires used in cardiovascular surgery, has appointed Daniel Johnson successor to its retiring chief financial officer James Stolze. Mr Johnson, who is currently executive vice-president and CFO of automobile parts manufacturer United Components, will join St Louis, Missouri-based Stereotaxis in September, and officially assume his new position on November 15. He brings to the company over 15 years' senior financial management experience. Mr Stolze will retire at the end of 2009, but will remain as consultant to Stereotaxis until June 2011.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.